Processing Your Payment

Please do not leave this page until complete. This can take a few moments.

Poll results

The BIOSECURE Act, a bipartisan piece of federal legislation under consideration by Congress, would cut off federal funding for biotech companies with close ties to governments considered to be foreign adversaries, including China. The legislation would require American companies to terminate any outsourcing agreements or equipment contracts with foreign companies deemed to be security risks.

Supporters of the legislation in Congress argue that biotech companies with ties to the Chinese Communist Party or military pose a national security risk, expressing concern about foreign adversaries having the potential to disrupt supply chains or have access to Americans’ genetic data. Some in the life science industry have expressed concerns about the potential disruptful impact of this legislation.  

The House bill currently has ten co-sponsors, including Rep. Jake Auchincloss (D-Newton) and Rep. Seth Moulton (D-Salem).

The bill would give the federal government the authority to add entities to a list of companies of concern. The most recent version of the legislation specifically targets five entities, including WuXi Biologics, a Chinese company constructing a $300-million, 189,500-square-foot biomanufacturing facility in Worcester expected to be operational in 2025. The City of Worcester had reported a pause of construction at the site, although work appears to be continuing.

Should the U.S. government ban federal funding and American cooperation with WuXi Biologics and other biotech companies who allegedly have close ties to foreign adversaries?
Yes. Companies with ties to foreign adversaries represent a grave national security threat, and we can’t afford to take risks. (43%, 54 VOTES)
Yes. However, the legislation should take steps to minimize the disruption these bans will have on American companies. (23%, 29 VOTES)
No. We need specific proof of nefarious actions by firms before taking any action negatively impacting the life science sector. (22%, 28 VOTES)
No. We need global cooperation to find cures and treatments for cancer and other devastating diseases. (11%, 14 VOTES)
Poll Description

The BIOSECURE Act, a bipartisan piece of federal legislation under consideration by Congress, would cut off federal funding for biotech companies with close ties to governments considered to be foreign adversaries, including China. The legislation would require American companies to terminate any outsourcing agreements or equipment contracts with foreign companies deemed to be security risks.

Supporters of the legislation in Congress argue that biotech companies with ties to the Chinese Communist Party or military pose a national security risk, expressing concern about foreign adversaries having the potential to disrupt supply chains or have access to Americans’ genetic data. Some in the life science industry have expressed concerns about the potential disruptful impact of this legislation.  

The House bill currently has ten co-sponsors, including Rep. Jake Auchincloss (D-Newton) and Rep. Seth Moulton (D-Salem).

The bill would give the federal government the authority to add entities to a list of companies of concern. The most recent version of the legislation specifically targets five entities, including WuXi Biologics, a Chinese company constructing a $300-million, 189,500-square-foot biomanufacturing facility in Worcester expected to be operational in 2025. The City of Worcester had reported a pause of construction at the site, although work appears to be continuing.

  • 125 Votes
  • 0 Comments
View recent polls

Sign up for Enews